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Abstract	
The	ability	of	a	polymer	therapeutic	to	access	the	appropriate	subcellular	location	is	crucial	to	
its	efficacy,	and	is	defined	to	a	large	part	by	the	many	and	complex	cellular	biological	and	
biochemical	barriers	such	a	construct	must	traverse.	It	is	shown	here	that	model	dextrin	
conjugates	are	able	to	pass	through	a	cartilaginous	extracellular	matrix	into	chondrocytes,	with	
little	perturbation	of	the	matrix	structure,	indicating	that	targeting	of	potential	therapeutics	
through	a	cartilaginous	extracellular	matrix	should	prove	possible.	Rapid	chondrocytic	targeting	
of	drugs	which	require	intracellularisation	for	their	activity,	and	uniform	extracellular	
concentrations	of	drugs	with	an	extracellular	target,	is	thus	enabled	though	polymer	
conjugation.	
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Introduction	
Articular	cartilage	lines	the	load	bearing	joints	of	the	body	acting	to	reduce	friction	and	absorb	
mechanical	loads.	It	is	an	aneural,	avascular,	hypocellular	tissue,	composed	of	a	dense	
extracellular	matrix	controlled	and	secreted	by	the	chondrocytes	within	it.	The	chondrocytes	
comprise	less	than	2%	of	the	volume	of	mature	articular	cartilage	with	the	remainder	
comprising	a	highly	organised	network	of	collagen	fibrils,	proteoglycans	and	water.	The	matrix	
macromolecules	of	articular	cartilage	give	the	tissue	its	unique	structure	and	function.	These	
structural	macromolecules	include	collagens	(mainly	type	II),	proteoglycans	and	non-
collagenous	proteins.	The	type	II	collagen	fibril	meshwork	gives	the	cartilage	its	form	and	
tensile	strength.	The	proteoglycans	and	non-collagenous	proteins	of	articular	cartilage	bind	to	
the	collagen	meshwork	or	become	mechanically	entrapped	within	it.	The	major	proteoglycan	of	
articular	cartilage	is	aggrecan,	which	has	numerous	glycosaminoglycan	chains	attached	to	its	
core	protein	and	forms	huge	multimolecular	aggregates	with	hyaluronan	and	a	link	protein.	
Hydration	of	the	glycosaminoglycan	chains	of	aggrecan	provides	cartilage	with	its	
compressibility	functions.	
More	than	ten	million	people	in	the	UK	have	long-term	health	problems	due	to	arthritis	or	a	
related	condition1.	The	most	common	arthritic	diseases	are	osteoarthritis	and	rheumatoid	
arthritis,	both	of	which	involve	erosion	of	the	cartilage	cushioning	the	ends	of	bones	within	the	
joint.	Symptoms	include	joint-pain	and	stiffness,	which	can	lead	to	disability.	Cartilage	
degeneration	in	arthritis	is	due	ultimately	to	the	enzymatic	degradation	of	the	cartilage	
extracellular	matrix.	The	complexity	and	density	of	the	cartilage	extracellular	matrix	results	in	a	
barrier	to	the	passage	of	molecules	through	the	matrix,	however	its	maintenance	is	crucial	for	
tissue	function.	In	the	synovial	joint	the	articular	surface	is	lubricated	and	nourished	by	synovial	
fluid,	a	filtrate	of	blood	plasma	containing	high	levels	of	the	glycosaminoglycan	hyaluronan	and	
the	proteoglycan	lubricin	(SZP)2.	The	relative	viscosity	of	synovial	fluid	provides	an	additional	
barrier	to	diffusion	of	molecules	into	chondrocytes.		
                                                
1. Arthritis	and	work	(03.2017)	http://www.arthritisresearchuk.org/policy-and-public-affairs/reports-and-
resources/reports/work-report.aspx			
2. Rhee,	D.K.,	Marcelino,	J.,	Baker,	M,	Gong,	Y.,	Smits,	P.,	Lefebvre,	V.,	Jay,	G.D.,	Stewart,	M.,	Wang,	H.,	
Warman,	M.L.	and	Carpten,	J.D.	(2005)	The	secreted	glycoprotein	lubricin	protects	cartilage	surfaces	and	
inhibits	synovial	cell	overgrowth.	The	Journal	of	Clinical	Investigation.	115:	622-631	
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Current	therapies	for	arthritis	mainly	treat	the	clinical	disease	symptoms	rather	than	targeting	
the	degradative	enzymes	themselves.	Treatments	such	as	steroidal	and	non-steroidal	anti-
inflammatory	drugs	are	still	the	mainstay	of	treatment3,4	and	can	have	adverse	side	effects	
including	high	blood	pressure5,6,7,	osteoporosis8,	cataracts9,10		and	gastrointestinal	bleeding11.	
The	newly	released	anti-TNF	drugs	(Etanercept,	Infliximab	and	Adalimumab)	which	block	the	
pro-inflammatory	cytokine	TNF	in	rheumatoid	and	psoriatic	arthritis12,13	are	efficacious	for	only	
a	small	cohort	of	patients	and	are	only	prescribed	for	UK	patients	with	severe	and	crippling	
forms	of	the	disease	as	they	carry	the	risk	of	serious	side	effects	due	to	immuno-suppression14.	
In	recent	years,	a	number	of	compounds	have	been	identified,	in	in	vitro	studies,	that	are	able	
to	inhibit	the	initial	loss	of	the	extracellular	matrix	component	aggrecan,	via	often	unknown	
mechanistic	inhibition	of	the	proteases	ADAMTS-4	and	/	or	-5.	These	compounds	have	notably	
                                                
3. Marini,	S.,	Fasciglione,	G.F.,	Monteleone,	G.,	Maiotti,	M.,	Tarantino,	U.	&	Coletta,	M.	(2003)	A	correlation	
between	knee	cartilage	degradation	observed	by	arthroscopy	and	synovial	proteinases	activities.	Clinical	
Biochemistry	36:	295-304;			
4. Brandt,	K.D.	&	Slowman-Kovacs,	S.	(1986)	Nonsteroidal	anti-inflammatory	drugs	in	treatment	of	
osteoarthritis.	Clinical	Orthopaedics	213:	84-91	
5. Gabriel,	S.E.	&	Wagner,	J.L.	(1997)	Costs	and	effectiveness	of	nonsteroidal	anti-inflammatory	drugs.	The	
importance	of	reducing	side	effects.	Arthritis	Care	Research	10:56-63	
6		 Hammer,	F.	&	Stewart,	P.M.	(2006)	Cortisol	metabolism	in	hypertension.	Best	Practice	and	Research	
Clinical	Endocrinology	and	Metabolism	20:	337-353	
7		 Reiche,	M.L.	(2005)	Complications	of	intravitreal	steroid	injections.	Clinical	Care	76:	450-460	
8	 Ledford,	D.,	Apter,	A.,	Brenner,	A.M.,	Rubin,	K.,	Frieri,	M.	&	Lukert,	B.	(1998)	Osteoporosis	in	the	
corticosteroid	treated	patient	with	asthma.	Journal	of	Allergy	and	Clinical	Immunology	102:	353-363	
9		 Moore,	P.	(1997)	Inhaled	corticosteroids	increase	cataract	risk.	The	Lancet	350:	120	
10		 Urban	R.C.	&	Cotlier,	E.	(1986)	Corticosteroid-induced	cataracts.	Survey	of	Ophthalmology	31:	102-110	
11		 Tringham,	V.M.	&	Cochrane,	P.	(1979)	Aspirin,	paracetamol,	diflunisal	and	gastrointestinal	blood	loss.	The	
Lancet	320:	1409	
12		 Punzi,	L.,	Podswiadek,	M.,	Sfriso,	P.,	Oliviero,	F.,	Fiocco,	U.	&	Todesco,	S.	(2007)	Pathogenic	and	clinical	
rationale	for	TNF-blocking	therapy	in	psoriatic	arthritis.	Autoimmunity	Reviews	6(8):	524-528	
13		 Berthelot,	J-M.,	Varin,	S.,	Cormier,	G.,	Tortellier,	L.,	Guillot,	P.,	Glemarec,	J.	&	Maugars,	Y.	(2007)	25mg	
etanercept	once	weekly	in	rheumatoid	arthritis	and	spondylarthropathy.	Joint	Bone	Spine	74(2):	144-147	
14		 Maillard,	H.,	Ornetti,	P.,	Grimault,	L.,	Ramon,	J-F.,	Ducamp,	S.M.,	Saidani,	T.,	Tavernier,	C.	&	Maillefert,	J.F.	
(2005)	Severe	pyogenic	infections	in	patients	taking	infliximab.	A	regional	cohort	study.	Joint	Bone	Spine	
72:	330-334	
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included	the	neutraceutical	glucosamine15,16,17	and	the	sulphated	sugar	derivative	pentosan	
polysulphate18,19.	In	addition,	the	physiological	inhibitor	of	ADAMTS-4	and	-5,	TIMP-3,	has	been	
shown	to	ablate	the	initial	loss	of	aggrecan	in	cytokine	induced	degradative	mechanisms20.		
The	idea	that	water-soluble	polymers	functioning	as	carriers	of	drugs	through	conjugation	via	a	
biodegradable	spacer	/	linker	could	facilitate	targeted	drug	release	was	first	put	forward	in	the	
mid-1970’s21.	The	last	two	decades	have	seen	successful	clinical	application	of	polymer	
conjugates	to	target	therapeutic	agents	for	the	treatment	of	a	range	of	diseases	including	age	
related	macular	degeneration,	cancer	and	liver	disease22,23,24,25.	These	therapeutic	conjugates	
have	utilised	a	number	of	polymers	as	drug	delivery	vehicles	including	N-(2-hydroxypropyl)	
                                                
15		 Largo,	R.,	Alvarez-Soria,	M.A.,	Diez-Ortego,	I.	&	Calvo,	E.	(2003)	Glucosamine	inhibits	IL-1b-induced	NFkB	
activation	in	human	osteoarthritic	chondrocytes.	Osteoarthritis	and	Cartilage	11:	290-298	
16		 Maillard,	H.,	Ornetti,	P.,	Grimault,	L.,	Ramon,	J-F.,	Ducamp,	S.M.,	Saidani,	T.,	Tavernier,	C.	&	Maillefert,	J.F.	
(2005)	Severe	pyogenic	infections	in	patients	taking	infliximab.	A	regional	cohort	study.	Joint	Bone	Spine	
72:	330-334	
17		 Ilic,	M.Z.,	Martinac,	B.	&	Handley,	C.J.	(2003)	Effects	of	long-term	exposure	to	glucosamine	and	
mannosamine	on	aggrecan	degradation	in	articulat	cartilage.	Osteoarthritis	and	Cartilage	11:	1-10	
18		 Smith,	J.G.,	Hannon,	R.L.,	Brunnberg,	L.,	Gebski,	V.	&	Cullis-Hill,	D.	(2002)	A	multicentre	clinical	study	of	
the	efficacy	of	sodium	pentosan	polysulphate	and	carprofen	in	canine	osteoarthritis	(osteoarthrosis).	
19		 Rogachefsky,	R.A.,	Dean,	D.D.,	Howell,	D.S.	&	Altman,	R.D.	(1994)	Treatment	of	canine	osteoarthritis	with	
sodium	pentosan	polysulphate	and	insulin-like	growth	factor-1.	Annal	of	the	New	York	Academy	of	
Sciences	732:	392-394	
20		 Gendron,	C.,	Kashiwagi,	M.,	Hughes,	C.E.,	Caterson,	B.	&	Nagase,	H.	(2003)	TIMP-3	inhibits	aggrecanases-
mediated	glycosaminoglycan	release	from	cartilage	explants	stimulated	by	catabolic	factors.	FEBS	Letters	
555:	431-436	
21		 Vasey,	P.A.,	Kaye,	S.B.,	Morrison,	R.,	Twelves,	C.,	Wilson,	P.,	Duncan,	R.,	Thomson,	A.H.,	Murray,	L.S.,	
Hilditch,	T.E.,	Murray,	T.,	Burtles,	S.,	Fraier,	D.,	Frigerio,	E.	&	Cassidy,	J.	(1999)	Phase	I	Clinical	and	
Pharmacokinetic	study	of	PK1	[N-(2-Hydroxypropyl)	methacrylamide	Copolymer	Doxorubicin]:	First	
member	of	a	new	class	of	chemotherapeutic	agents-	drug-polymer	conjugates.	Clinical	Cancer	Research	5:	
83-94	
22		 Duncan,	R.	(2005)	Targeting	and	intracellular	delivery	of	drugs.	In	Encyclopedia	of	Molecular	Cell	Biology	
and	Molecular	Medicine,	Editor	Meyers,	R.A.,	Published	by	Wiley-VCH,	Verlag,	GmbH	&	Co.	KGaA,	
Weinheim,	Germany,	pp163-204	
23		 Duncan,	R.	(2006)	Polymer	conjugates	as	anticancer	nanomedicines.	Nature	Reviews	Cancer	6:	688-701	
24		 Duncan,	R.,	Ringsdorf,	H.	&	Satchi-Fainaro,	R.	(2006)	Polymer	therapeutics	–	Polymers	as	Drugs,	
Conjugates	and	Gene	Delivery	Systems:	Past,	present	and	future	opportunities.	Advanced	Polymer	
Science	192:	1-8	
25		 Yasukawa,	T.,	Ogura,	Y.,	Sakurai,	E.,	Tabata,	Y.	&	Kimura,	H.	(2005)	Intraocular	sustained	drug	delivery	
using	implantable	polymeric	devices.	Advanced	Drug	Delivery	Reviews	57:	2033-2046	
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methacrylamide	(HPMA)26,27,	poly(ethylene	glycol)	(PEG)28,29,30	and	dextrin31,32.	Conjugation	of	
drugs	to	polymers	has	allowed	for	specific	targeting	of	the	therapeutic	activity	of	a	drug	to	the	
diseased	tissue.	This	results	in	a	reduction	in	the	dose	required	for	efficacy	of	treatment	and	a	
reduction	in	potential	toxicity	of	the	drugs.		
Expanding	this	modality	to	the	treatment	of	arthritic	joints,	requires	that	such	polymers	in	
order	to	deliver	their	drug	payload	must	be	able	to	pass	through	a	cartilaginous	extracellular	
matrix	rich	in	negatively	charged	proteoglycans,	either	to	reach	their	chondrocytic	targets,	or	to	
achieve	even	distribution	throughout	the	cartilage	extracellular	matrix.	In	the	selection	of	
suitable	targeting	polymers	and	polymer	conjugates	for	the	treatment	of	arthritic	disease,	
quantifying	whether	these	compounds	can	indeed	pass	through	the	barriers	presented	by	the	
synovial	joint	without	inducing	their	disruption	will	be	of	vital	importance.	Of	the	potential	
barriers	present	we	believe	that	the	interactions	of	polymers	and	polymer	conjugates	with	
proteoglycans,	within	the	cartilage	extracellular	matrix	as	well	as	coating	its	surface,	will	be	the	
most	influential	on	their	movement.	This	study	focused	on	investigating	the	interactions	of	
polymers	and	polymer	conjugates	with	the	cartilage	proteoglycans	aggrecan	and	lubricin	as	
well	as	synovial	fluid.	
	
                                                
26		 Duncan,	R.,	Vicent,	M.J.,	Greco,	F.	&	Nicholson,	R.I.	(2005)	Polymer-drug	conjugates:	towards	a	novel	
approach	for	the	treatment	of	endocrine-related	cancer.	Endocrine-Related	Cancer	12:	189-199	
27		 Nan,	A.,	Nanayakkara,	N.P.D.,	Walker,	L.A.,	Yardley,	V.,	Croft,	S.L.	&	Ghandehari,	H.	(2001)	N-(2-
hydroxypropyl)methacrylamide	(HPMA)	copolymers	for	targeted	delivery	of	8-aminoquinoline	
antileishmanial	drugs.	Journal	of	Controlled	Release	77:	233-243	
28		 Ould-Ouali,	L.,	Noppe,	M.,	Langlois,	X.,	Willems,	B.,	Riele,	P.T.,	Timmerman,	P.,	Brewster,	M.E.,	Arien,	A.	&	
Preat,	V.	(2005)	Self-assembling	PEG-r(CL-co-TMC)	copolymers	for	oral	delivery	of	poorly	water	soluble	
drugs:	a	case	study	with	risperidone.	Journal	of	Controlled	Release	102:	657-668	
29		 Cheng,	J.,	Teply,	B.A.,	Sherifi,	I.,	Sung,	J.,	Luther,	G.,	Gu,	F.X.,	Levy-Nissenbaum,	E.,	Radovic-Moreno,	A.F.,	
Langer,	R.	&	Farokhzad,	O.C.	(2007)	Formulation	of	functionalised	PLGA-PEG	nanoparticles	for	in	vivo	
targeted	drug	delivery.	Biomaterials	28:	869-876	
30		 Yu,	D.,	Peng,	P.,	Dharap,	S.S.,	Wang,	Y.,	Mehlig,	M.,	Chandna,	P.,	Zhao,	H.,	Filpula,	D.,	Yang,	K.,	Borowski,	
V.,	Borchard,	G.,	Zhang,	Z.	&	Minko,	T.	(2005)	Antitumor	activity	of	poly(ethylene	glycol)-camptothecin	
conjugate:	The	inhibition	of	tumor	growth	in	vivo.	Journal	of	Controlled	Release	110:	90-102	
31		 Hreczuk-Hirst,	D.,	Chicco,	D.,	German,	L.	&	Duncan,	R.	(2001)	Dextrins	as	potential	carriers	for	drug	
targeting:	tailored	rates	of	dextrin	degradation	by	introduction	of	pendant	group.	International	Journal	of	
Pharmaceutics	230:	57-66	
32		 Hreczuk-Hirst,	D.,	German,	L.	&	Duncan,	R.(2001)	Dextrins	as	carriers	for	drug	targeting:	Reproducible	
succinoylation	as	a	means	to	introduce	pendant	groups.	Journal	of	Bioactive	and	Compatible	Polymers	16:	
353-364	
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Materials	&	Methods	
Preparation	of	synovial	fluid	samples	
Synovial	fluid	samples	were	harvested	from	the	metacarpo	/	metatarso	phalangeal	joints	of	18	
month	old	cows	legs	using	a	15	gauge	needle.		
Preparation	of	lubricin	
Following	effusion	of	the	synovial	fluid	from	the	joints	of	18	month	old	cows	legs	as	described	
above	the	joints	were	lavaged	using	1.6M	sodium	chloride	to	isolate	the	lubricin	coating	the	
surface	of	the	articular	cartilage33.	
Preparation	of	aggrecan	aggregates	
Bovine	articular	cartilage	explants	were	established	using	previous	methodologies34.	Following	
a	48	hour	preculture	explants	were	washed	into	serum	free	DMEM.		The	explants	were	then	
cultured	in	either	(i)	serum	free	DMEM	or	(ii)	serum	free	DMEM	+	IL-1a	(10ng/ml).		Cultures	
were	incubated	for	up	to	96	hours;	media	and	explants	were	harvested	and	finely	diced	prior	to	
addition	of	guanidine	extraction	buffer	(4M	guanidine	HCl,	50mM	sodium	acetate	pH	5.8-6.8,	
0.1M	6-amino-hexanoic	acid,	5mM	benzamidine	HCl,	10mM	ethylene	diaminetetra	acetic	acid	
(EDTA)	(tetrasodium	salt),	1mM	phenyl	methyl	sulphonyl	fluoride	(PMSF	-	10ml	per	gram	
cartilage	wet	weight)	and	incubated	for	48	hours	at	4oC	with	constant	agitation.	The	extracted	
cartilage	debris	was	removed	by	centrifugation	at	15,000rpm	for	10	minutes,	and	discarded.	
The	liquid	supernatant	was	then	dialysed	exhaustively	against	MilliQ™	water.	The	density	of	the	
extract	was	adjusted	to	1.5g/ml	by	addition	of	CaCl2	and	aggrecan-hyaluronan	aggregate	
purified	by	ultracentrifugation	in	a	Beckman	L-60	Ultracentrifuge	at	37,000rpm	for	70	hours	at	
4oC.	The	extract	was	fractionated	into	4	equal	pools	designated	A1-A4,	the	lowest	fraction	A1	
containing	the	purified	aggrecan-hyaluronan	complex	and	having	a	density	>1.57g/ml.	
                                                
33		 Jones,	A.R.C.,	Gleghorn,	J.P.,	Hughes,	C.E.,	Fitz,	L.J.,	Zollner,	R.,	Wainwright,	S.D.,	Caterson,	B.,	Morris,	E.A.,	
Bonassar,	L.J.	and	Flannery,	C.R.	(2007)	Binding	and	localization	of	recombinant	lubricin	to	articular	
cartilage	surfaces.	Journal	of	Orthopaedic	Research	25(3):	283-92.	
34		 Hughes,	C.E.,	Caterson,	B.,	Fosang,	A.J.,	Roughley,	P.J.	and	Mort,	J.S.	(1995)	Monoclonal	antibodies	that	
specifically	recognise	neoepitope	sequences	generated	by	aggrecanases	and	matrix	metalloproteinase	
cleavage	of	aggrecan:	application	to	catabolism	in	situ	and	in	vitro.	The	Biochemical	Journal	305:	799-804	
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Analysis	of	cellular	uptake	of	polymer	conjugates	by	FACS	and	fluorescence	microscopy	
Explants	were	harvested	and	pre-cultured	using	previously	established	methodsError!	Reference	
source	not	found.	prior	to	incubation	in	the	presence	or	absence	of	IL-1a	(10ng/ml)	for	96	hours35.	
Cultures	were	then	incubated	in	DMEM	with	50µg/ml	gentamicin	and	10%	(v/v)	heat	
inactivated	FBS	in	the	presence	or	absence	of	Oregon	Green	labelled	polymers	at	a	range	of	
concentrations	(1-10µg/ml)	for	a	number	of	time	points	(2-24	hours).	Following	incubation	with	
polymers	explants	were	either	washed	in	phosphate	buffered	saline	and	viewed	using	a	
confocal	microscope,	or	digested	to	free	the	cells	using	Pronase	(1%	{w/v}	in	DMEM	containing	
50µg/ml	gentamicin	and	10%	{v/v}	heat	inactivated	FBS)	for	30	minutes	at	37oC,	followed	by	
collagenase	type	II	(0.4%	{w/v}	in	DMEM	containing	50µg/ml	gentamicin	and	10%	{v/v}	heat	
inactivated	FBS)	for	45	minutes	at	37oC.	The	isolated	cells	will	be	pelleted	by	centrifugation	
resuspended	in	PBS	and	run	on	a	FACs	Canto	(BD	Biosciences).	
Pulsed-Gradient	Spin-Echo	Nuclear	Magnetic	Resonance	
Measurements	on	the	purified	freeze-dried	aggrecan-hyaluronan	complex	redispersed	in	D2O	
were	conducted	on	a	Bruker	AMX360	NMR	spectrometer	using	a	stimulated	echo-sequence36.		
This	configuration	used	either	a	5mm	(Cryomagnet	Systems,	Indianapolis)	or	10mm	(Bruker)	
diffusion	probe	in	conjunction	with	Bruker	or	Woodward	gradient	spectroscopy	accessories.	
The	self-diffusion	coefficient	Ds	was	extracted	by	fitting	to	equation	1	either	(i)	the	integrals	for	
a	given	peak,	or	(ii)	the	individual	frequency	channels	present	in	the	entire	bandshape	(CORE	
analysis);	
	
(1)	
                                                
35		 Arner,	E.C.,	Hughes,	C.E.,	Decicco,	C.P.,	Caterson,	B.	and	Tortorella,	M.D	(1998)	Cytokine	induced	cartilage	
proteoglycan	degradation	is	mediated	by	aggrecanases.	Osteoarthritis	and	Cartilage.	6:	214-228	
36		 Davies,	J.A.	and	Griffiths,	P.C.	(2003)	A	Phenomenological	Approach	to	Separating	the	Effects	of	
Obstruction	and	Binding	for	the	Diffusion	of	Small	Molecules	in	Polymer	Solutions.	Macromolecules:	36,	
950	
( ) [ ]so kDAGA −=Δ exp,,δ
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where	A	is	the	signal	amplitude	in	the	absence	(Ao)	and	presence	of	the	field	gradient	pulses
( )Δ,,GA δ )	and	 ( ) ( )
⎟
⎟
⎠
⎞
⎜
⎜
⎝
⎛ +++−+Δ
−=
30
1435301030 23223222 σσδσδδσδγ Gk 		
given	that	g	is	the	magnetogyric	ratio,	D	the	diffusion	time,	σ	the	gradient	ramp	time,	d	the	
gradient	pulse	length	and	G	the	gradient	field	strength.	
	
Small-angle	neutron	scattering	
SANS	experiments	were	performed	on	the	LOQ	diffractometer	based	at	the	spallation	source	at	
the	Rutherford	Appleton	Laboratory,	U.K.,	where	a	Q	range	of	0.007	Å-1	to	0.3	Å-1	is	accessible	
using	2	<	l	<	10	Å	,	where	Q	=	(4π/λ)sin(θ/2)Q = #$% sin )* .		
	
Samples	were	contained	in	1	mm	pathlength,	UV-spectrophotometer	grade,	quartz	cuvettes	
(Hellma)	and	mounted	in	aluminium	holders	on	top	of	an	enclosed,	computer-controlled,	
sample	chamber.	Temperature	control	was	achieved	through	the	use	of	a	thermostatted	
circulating	bath	pumping	fluid	through	the	base	of	the	sample	chamber.	Under	these	conditions	
a	temperature	stability	of	better	than	±	0.5°C	can	be	achieved.	Experimental	measuring	times	
were	approximately	40-60	min.	
	
All	scattering	data	were	normalised	for	the	sample	transmission	and	the	incident	wavelength	
distribution,	corrected	for	instrumental	and	sample	backgrounds	using	a	quartz	cell	filled	with	
either	H2O	or	D2O	(this	also	removes	the	incoherent	instrumental	background	arising	from	
vacuum	windows,	etc.),	and	corrected	for	the	linearity	and	efficiency	of	the	detector	response	
using	the	instrument	specific	software	package.	The	data	were	put	onto	an	absolute	scale	using	
a	well-characterized	partially	deuterated	polystyrene	blend	standard	sample.		
	
The	intensity	of	the	scattered	radiation,	I(Q),	as	a	function	of	the	wavevector,	is	given	by:		
	
          𝐼 𝑄 = 𝑁𝑉* 𝛥𝜌 *𝑃 𝑄 𝑆 𝑄 +	𝐵678           (2)                           
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where	P(Q)	describes	the	morphology	of	the	scattering	species,	S(Q)	describes	the	spatial	
arrangement	of	the	species	in	solution,	N	is	the	number	of	species	per	unit	volume,	V	is	the	
volume	of	the	species,	Δρ	is	the	difference	in	the	neutron	scattering	length	density	(SLD)	of	the	
scatterer	and	the	solvent	and	Binc	is	the	incoherent	background	scattering. 	
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Results	and	Discussion	
PGSE-NMR	provides	a	convenient	and	non-invasive	chemically	selective	technique	for	
measuring	translational	motion,	and	in	particular	the	self-,	rather	than	mutual-	diffusion	
coefficient.	Therefore,	PGSE-NMR	can	be	used	both	to	quantify	the	mobility	of	molecules	and	
to	assess	the	impact	of	the	presence	of	the	molecules	on	the	extracellular	matrix	components	
themselves.	The	diffusion	of	small	solutes	(including	water	and	Na+)	has	been	shown	to	be	
impeded	by	up	to	40%	by	the	presence	of	an	extracellular	matrix,	implying	that	the	movement	
of	larger	molecules	such	as	polymers	may	be	very	significantly	affected	by	the	presence	of	a	
matrix37.		
A	vital	component	in	the	selection	of	polymer-drug	conjugates	for	the	treatment	of	arthritic	
disease	is	the	selection	of	either	polymers	able	to	target	a	drug	with	intracellular	activity	and	its	
ability	to	diffuse	rapidly	through	the	extracellular	matrix	into	the	chondrocyte.	Accordingly,	the	
rate	of	diffusion	of	dextrin	polymers	(as	model	conjugates)	has	been	quantified	both	in	free	
solution	and	through	components	of	the	cartilaginous	extracellular	matrix	(an	aggrecan-
hyaluronan	aggregate	gel	purified	by	density	gradient	centrifugation	from	bovine	articular	
cartilage),	Table	One.	For	the	Mw	=	10k	g/mol-1	dextrin	sample,	the	self-diffusion	coefficient	was	
slowed	from	Ds	=	2.7	x	10-10	m2s-1	in	free	solution,	corresponding	to	a	hydrodynamic	radius	of	a	
few	nanometres,	to	Ds	=	2.6	x	10-11	m2s-1	in	the	aggrecan-hyaluronan	gel,	(Table	1).	The	higher	
molecular	weight	dextrin	shows	a	larger	reduction,	though	the	free	solution	retardation	is	
consistent	with	the	increase	in	molecular	weight	of	a	random	coil	configuration.	By	drawing	
analogies	of	the	diffusion	of	such	polymer	in	related	(mucin)	gels,	this	significant	retardation	is	
probably	not	a	consequence	of	direct	association	of	the	dextrin	with	the	aggrecan-hyaluronan	
aggregate,	but	rather	steric	hindrance	due	to	the	presence	of	the	highly	entangled	matrix	of	the	
aggrecan-hyaluronan	aggregate38.	The	non-linearity	of	the	attenuation	function	clearly	
demonstrates	the	presence	of	more	than	a	single	diffusion	rate	and	the	CORE	analysis	identifies	
                                                
37		 Burstein,	D.,	Gray,	M.L.,	Hartman,	A.L.,	Gipe,	R.	and	Foy,	B.D.	(1993)	Diffusion	of	small	solutes	in	cartilage	
as	measured	by	nuclear	magnetic	resonance	(NMR)	spectroscopy	and	imaging.	Journal	of	Orthopaedic	
Research.	11:	465-478	
38		 Griffiths,	P.C.,	Occhipinti,	P.,	Gumbleton,	M.,	Morris,	C.J.,	Heenan,	R.K.	and	King,	S.M.	(2010)	PGSE-NMR	
and	SANS	Studies	of	the	Interaction	of	Model	Polymer	Therapeutics	with	Mucin	Biomacromolecules.	11:	
120-125	
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these	to	be	dextrin	(the	initial	decay)	and	the	underlying	much	slower	(two	orders	of	magnitude	
slower)	diffusion	of	the	aggrecan-hyaluronan	aggregates.	
As	an	aside,	we	can	also	comment	on	the	effect	of	succinoylation	–	the	first	step	in	dextrin	
functionalisation	–	on	the	conformation	of	the	polymer,	as	characterised	by	their	self-diffusion	
coefficients,	figure	2.	The	self-diffusion	coefficient	drops	smoothly	(increasing	hydrodynamic	
size)	with	increasing	mole	percent	of	succinoylation,	up	to	a	value	of	around	~10mol%,	above	
which	the	self-diffusion	coefficient	becomes	largely	constant	at	~1	x	10-10	m2s-1,	consistent	with	
an	hydrodynamic	radius	of	around	50Å.	
The	(gel)	structure	of	cartilage	extract,	and	various	derivative	materials	have	been	examined	by	
small-angle	neutron	scattering	(SANS)	in	the	absence	and	presence	of	added	dextrin,	figures	
3a&b	(representative	data	only	presented).	In	the	case	of	the	18m	direct	cartilage	extract,	
where	the	scattering	from	the	gel	itself	is	significant	(I(Q)	>	10	cm-1	at	Q	<	0.01	Å)	and	
dominates	the	mixture	scattering	(for	dextrin,	I(Q)	<	0.5	cm-1	at	Q	<	0.01	Å),	addition	of	the	two	
dextrin	samples	induced	no	noticeable	perturbation	in	the	scattering	-	and	hence,	structure	of	
the	direct	cartilage	extract	gel.	In	the	case	of	the	IL-1	systems,	and	various	other	derivative	
materials	(data	not	presented),	figure	3b,	the	same	conclusion	may	be	drawn,	but	not	so	
directly.	It	is	obvious	that	the	scattering	does	vary	across	the	different	mixed	systems,	but	it	is	
shown	below	that	this	is	a	consequence	of	the	weaker	and	comparable	intensities	of	the	
various	components	rather	than	one	dominating	contribution,	as	in	the	case	of	the	18m	direct	
cartilage	extract.			
A	number	of	strategies	exist	for	interpreting	SANS	data.	The	simplest	is	to	consider	the	slope	of	
the	data	when	plotted	on	a	double	logarithmic	representation,	extracting	the	so-called	Q	
dependency,	I(Q)	 µ	Q-n,	illustrating	the	most	probable	shape	of	the	scatterer;	n	=	1	indicates	a	
rod,		n	=	2	a	flat	structure,	increasing	all	the	way	to	n	=	4	for	a	large,	solid	object.	For	systems	
like	gels,	one	might	anticipate	n	=	5/3	to	the	n	=	3,	reflecting	a	transition	from	a	mass	to	volume	
fractal	character	associated	with	the	differing	length-scales	present	in	the	gel.	This	is	indeed	the	
case.	
Alternatively,	one	may	numerically	analyse	the	data	in	terms	of	specific	models,	based	on	some	
a	priori	knowledge	of	the	likely	conformation	or	arrangement	of	molecules	in	solution.	For	
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dextrin,	a	simple	polydisperse	Gaussian	coil	model	adequately	describes	the	data	for	Mw	=	51K	
g/mol-1	dextrin	sample,	with	RG	=	80	Å	(consistent	with	the	theoretical	prediction	for	the	ratio	of	
the	radius	of	gyration	and	hydrodynamic	radius,	RG/RH	=	1.5).		
For	the	gels,	an	appropriate	treatment	is	the	Shibayama-Geissler	two-length	scale	model39,40	
which	treats	the	scattering	as	the	additional	of	two	components,	with	fraction	f;	
𝐼 𝑄 = 𝑓𝐼(0)= ==> ?@AB CDEAD ?/D + 1 − 𝑓 𝐼 0 *𝑒𝑥𝑝 −𝑄*𝑎** + 𝐵	 	 	 (3)	
where	D	is	the	scaling	exponent	and	𝑎** ≈ NODP .	The	parameters	describing	the	Shibayama-
Geissler	fit	to	these	data	are	presented	in	Table	Two.	By	and	large,	the	fitting	is	most	sensitive	
to	the	Lorentzian	component	embodied	in	the	scaling	exponent	D,	with	a	length	scale	(𝑎=*)	of	
around	100	Å,	but	the	18m	direct	cartilage	extract	also	requires	a	Guinier	term,	with	length	
scale	slightly	shorter.		Most	importantly,	as	is	evident	from	the	raw	data	where	subtle	
differences	are	only	observed	at	higher	Q	values,	the	parameters	are	largely	insensitive	to	the	
addition	of	the	dextrin	i.e.	it	may	be	considered	to	be	non-perturbing.		
Having	shown	it	is	possible	for	dextrin	to	diffuse	through	the	gel	whilst	having	little	impact	on	
its	structure,	the	progression	of	(Oregon	Green	fluorophore	labelled)	dextrin	into	chondrocytes	
was	assessed.	Each	of	the	cultures	was	incubated	in	dextrin-Oregon	Green	at	1,	5	and	10µg/ml	
for	2-24	hours.	Cells	were	released	from	monolayer	cultures	by	gentle	trypsinisation	and	by	
rapid	pronase	and	collagenase	digest	from	explant	and	ex	vivo	transwell	grafts	cultures.	FACS	
analysis	of	these	cell	populations	with	10µg/ml	dextrin-Oregon	Green	at	2,	4,	8	and	24	hours	
are	shown	in	Figure	4.		
Cellular	uptake	of	the	dextrin	conjugate	achieved	in	the	presence	of	a	cartilaginous	extracellular	
matrix	in	both	explant	cultures	and	in	ex	vivo	transwell	grafts	(Figure	4B	&	A,	respectively).	In	
cartilage	explants	cellular	uptake	was	achieved	in	over	90%	of	cells	following	8	hours	exposure	
(Figure	4B).	Uptake	of	dextrin-Oregon	Green	was	slower	in	ex	vivo	transwell	grafts	than	in	
                                                
39		 Shibayama,	M.,	Toyoichi,	T.,	and	Han,	C.C.		(1992)	Small	angle	neutron	scattering	study	on	poly(N-
isopropyl	acrylamide)	gels	near	their	volume-phase	transition	temperature.	J.	Chem.	Phys.	97(9),	6829-
6841	
40	 Mallam,	S.,	Horkay,	F.,	Hecht,	A.M.,	Rennie,	A.R.	and	Geissler,	E.,	(1991)		Microscopic	and	macroscopic	
thermodynamic	observations	in	swollen	poly(dimethylsiloxane)	networks.	Macromolecules	24,	543	
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explants	cultures	with	only	66%	of	cells	containing	the	fluorophore	following	24	hours	exposure	
(Figure	4A).	In	the	ex	vivo	transwell	grafts	the	dextrin-Oregon	Green	was	only	added	to	the	
insert	medium	to	mimic	the	situation	in	vivo	where	a	therapeutic	agent	injected	into	the	joint	
would	only	be	able	to	penetrate	the	cartilage	at	the	articular	surface	(Figure	5).	This	restricted	
access	to	one	surface	explains	the	apparently	slower	rate	of	uptake	by	chondrocytes	within	the	
ex	vivo	transwell	grafts	compared	to	chondrocytes	within	cartilage	explants	(Figures	4	A	&	B).		
In	order	to	determine	whether	dextrin-Oregon	Green	was	able	to	pass	right	through	a	
cartilaginous	extracellular	matrix	it	was	only	added	to	the	insert	medium	of	the	ex	vivo	
transwell	grafts	and	both	the	insert	and	outer	medium	were	analysed	for	its	presence	using	
fluorescence	spectroscopy	following	a	number	of	different	incubation	times	(Figure	6).		
The	dextrin-Oregon	Green	was	able	to	pass	right	through	the	extracellular	matrix	of	the	ex	vivo	
transwell	grafts	and	was	detected	in	the	outer	medium	of	the	cultures	following	only	2	hours	of	
incubation	with	the	conjugate	(Figure	6).	Following	24	hours	incubation	on	the	filter	insert	
cultures	over	13%	of	the	total	fluorescence	present	in	the	cultures	was	detected	in	the	outer	
medium	(Figure	6).		
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Conclusions	
Combined,	the	data	presented	here	demonstrate	that	dextrin	is	able	to	successfully	diffuse	
through	a	cartilaginous	extracellular	matrix	and	into	the	chondrocytes	within,	inducing	little	
perturbation	in	that	matrix,	thus	indicating	the	feasibility	of	drug	delivery	using	polymer	
conjugates	for	the	treatment	of	arthritis.		
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Tables	
Sample	 Free	solution	 Aggrecan-hyaluronan	 Ratio	
Mw	=	10K	g/mol-1	 2.7	x	10-10	m2s-1	 2.6	x	10-11	m2s-1	 10	
Mw	=	51K	g/mol-1	 1.0	x	10-10	m2s-1	 5.0	x	10-12	m2s-1	 20	
Table	1;	Self-diffusion	coefficients	in	free	solution	(concentration	1wt%)	and	aggrecan-
hyaluronan	gels	measured	by	PGSE-NMR,	and	the	retardation	ratio	from	free	solution	to	gel.	
	
	
Sample	
Guinier	
scale	
Lorentzian	
scale	
Radius	of	
gyration	/	
Å	
Fractal	
dimension	
Correlation	
length	/	Å	
18m	 0.2	 18	 85	(+/-	3)	 2.2	(+/-	0.1)	 235	(+/-	30)	
18m	plus	dextrin	
10K	g	mol-1	
n/a	 18	 n/a	 2.3	 140	
18m	plus	dextrin	
51K	g	mol-1	
n/a	 14	 n/a	 2.3	 135	
IL-1	 n/a	 0.2	 n/a	 2.2	 105	
IL-1	plus	dextrin	
51K	g	mol-1	
0.3	 1.1	 55	 2.2	 90	
	
Table	2:		Parameters	derived	from	an	analysis	of	the	scattering	data	in	terms	of	the	Shibayama-
Geissler	two-length	scale	model.	 	
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Figures	
	
									 	
	
Figure	1.	Experimental	two-dimensional	PGSE	NMR	dataset	(left)	and	analysis	of	peak	integrals	
used	to	extract	the	rates	of	diffusion	(right)	for	Mw	=	10k	g/mol-1	dextrin	in	free	solution	and	in	
an	aggrecan-hyluronan	gel,	the	open	symbols	correspond	to	the	attenuation	function	for	the	
peak	at	~3ppm	in	the	spectrum	from	10mg/ml	(1wt%)	dextrin	in	solution	i.e.	the	raw	data	
presented	above.	The	filled	symbols	correspond	to	two	superimposed	datasets,	necessary	to	
span	the	wide	dynamics	range	present	in	these	systems,	again	for	the	3ppm	peak,	arising	from	
the	spectrum	of	10mg/ml	(1wt%)	dextrin	in	an	aggrecan-hyaluronan	gel	(20mg/ml	GAG).		
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Figure	Two;	Self-diffusion	coefficients	in	free	solution	as	a	function	of	degree	of	succinoylation	
measured	by	PGSE-NMR	for	dextrin	Mw	=	51K	g/mol-1	at	1wt%	polymer.	
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Figure	3a.	Small-angle	neutron	scattering	from	1mm	thick	(H2O)	aqueous	solutions	of	direct	
cartilage	extract	from	18	month	old	knee	joints	in	the	absence	of	dextrin,	and	in	the	presence	of	
1wt%	dextrin,	Mw	=	10k	g/mol-1	and	Mw	=	51k	g/mol-1.	The	lines	of	best	fit	have	been	derived	
from	the	analysis	using	the	Beaucage	model	as	described	in	the	text.	Also	shown	for	comparison	
is	the	scattering	from	1wt%	Mw	=	51k	g/mol-1	dextrin	(in	D2O).	The	lines	of	best	fit	for	this	
dextrin	sample	has	been	derived	from	a	simple	Gaussian	coil	model,	RG	=	80	(±	3)	Å.			
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Figure	3b.	Small-angle	neutron	scattering	from	2mm	thick	(D2O)	reconstituted	aqueous	
solutions	of	IL-1	in	the	absence	of	dextrin	and	in	the	presence	of	1wt%	dextrin	Mw	=	51k	g/mol-1.	
The	lines	of	best	fit	have	been	derived	from	the	analysis	using	the	gel	plus	coil	model	as	
described	in	the	text.	Also	shown	for	comparison	is	the	scattering	from	the	dextrin	solution.			
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																																																				A.	Transwell	Filter	Grafts																		B.	Cartilage	Explants																							
																																										 		
	
Figure	4;		FACS	analysis	of	dextrin-Oregon	Green	uptake	with	time	in:	(A)	chondrocytes	isolated	
from	ex	vivo	transwell	grafts	following	exposure	to	dextrin-Oregon	Green	and	(B)	chondrocytes	
isolated	from	articular	cartilage	explants	cultures	following	exposure	to	dextrin-Oregon	Green.		
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Figure	5:	Picture	of	ex	vivo	transwell	grafts	and	diagrammatic	representation	of	the	structure	of	
the	cultures	(insert)	
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Figure	6:	Analysis	of	the	distribution	of	fluorescence	in	transwell	filter	cultures	by	fluorescence	
spectroscopy.		
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1 2 3 4 5
P
r
o
p
r
o
ti
o
n
 o
f 
T
o
ta
l 
F
lu
o
r
e
s
c
e
n
c
e
 (
%
)
Cells / matrix / filter
Insert media 
Outer media 
Insert starting medium 
Outer  
Medium 
Cartilage matrix plug 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1 2 3 4 5
P
r
o
p
r
o
ti
o
n
 o
f 
T
o
ta
l 
F
lu
o
r
e
s
c
e
n
c
e
 (
%
)
 24 
	
